We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

346 hedge funds and large institutions have $7.99B invested in SALIX PHARMACEUTICALS LTD DEL in 2014 Q4 according to their latest regulatory filings, with 96 funds opening new positions, 120 increasing their positions, 112 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 112

2% more first-time investments, than exits

New positions opened: 96 | Existing positions closed: 94

1% less funds holding

Funds holding: 348 → 346 (-2)

24% less capital invested

Capital invested by funds: $10.6B → $7.99B (-$2.57B)

26% less funds holding in top 10

Funds holding in top 10: 19 → 14 (-5)

41% less call options, than puts

Call options by funds: $231M | Put options by funds: $389M

Holders
346
Holders Change
-2
Holders Change %
-0.57%
% of All Funds
9.23%
Holding in Top 10
14
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-26.32%
% of All Funds
0.37%
New
96
Increased
120
Reduced
112
Closed
94
Calls
$231M
Puts
$389M
Net Calls
-$158M
Net Calls Change
-$27.2M

Top Buyers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
+$703M
2
JHIU
Janus Henderson Investors US
Colorado
+$181M
3
Morgan Stanley
Morgan Stanley
New York
+$156M
4
O
OppenheimerFunds
New York
+$143M
5
Invesco
Invesco
Georgia
+$109M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$496M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$489M
3
TCIM
TIAA CREF Investment Management
New York
-$159M
4
Viking Global Investors
Viking Global Investors
Connecticut
-$119M
5
Citadel Advisors
Citadel Advisors
Florida
-$116M
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
26
Corvex Management
New York
$73.7M +$55.8M +460,800 +256%
BBA
27
Baker Bros. Advisors
New York
$73M +$75.9M +626,700 +7,269%
Franklin Resources
28
Franklin Resources
California
$72.1M +$11.5M +95,102 +18%
Northern Trust
29
Northern Trust
Illinois
$71.7M +$10.4M +85,642 +16%
Federated Hermes
30
Federated Hermes
Pennsylvania
$69.1M -$73.3M -605,202 -50%
American Century Companies
31
American Century Companies
Missouri
$68.9M +$2.33M +19,270 +3%
HCM
32
Hoplite Capital Management
New York
$66M – – –
HM
33
HealthCor Management
New York
$60.3M -$49.7M -410,100 -44%
Millennium Management
34
Millennium Management
New York
$58.8M -$25.1M -206,951 -29%
Point72 Asset Management
35
Point72 Asset Management
Connecticut
$57.8M +$42.7M +352,500 +235%
UBS AM
36
UBS AM
Illinois
$57.6M +$56.4M +465,688 +1,307%
Norges Bank
37
Norges Bank
Norway
$56.5M +$7.78M +64,245 +15%
SFM
38
Soros Fund Management
New York
$56.5M +$59.5M +491,531 New
NRC
39
North Run Capital
Massachusetts
$56.3M +$59.4M +490,000 New
DCM
40
Discovery Capital Management
Connecticut
$56M +$59.1M +487,500 New
Jennison Associates
41
Jennison Associates
New York
$54.9M +$57.8M +477,205 New
SI
42
Standard Investments
New York
$51.1M +$11.9M +98,151 +28%
T
43
TOBAM
France
$50.3M +$53M +437,377 New
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$45.9M +$39.6M +326,872 +451%
Ameriprise
45
Ameriprise
Minnesota
$45M -$79.3M -654,609 -63%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$44.6M +$2.34M +19,280 +5%
TA
47
Teachers Advisors
New York
$44M -$101M -831,326 -68%
First Trust Advisors
48
First Trust Advisors
Illinois
$43.2M -$10.8M -89,516 -19%
Deutsche Bank
49
Deutsche Bank
Germany
$43.1M +$20.5M +169,001 +82%
ZCI
50
Zevenbergen Capital Investments
Washington
$42.5M -$357K -2,950 -0.8%
1
2
3 4 5

SLXP Hedge Fund Activity: Q4 2014 in Review

346 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q4 2014, worth a combined $7.99B — down 24% from $10.6B a quarter earlier.

Buyers outnumbered sellers: 96 funds opened new SLXP positions and 94 closed out — a net gain of 2 holders — while 120 added to existing stakes and 112 trimmed.

The largest buyer was Paulson & Co, opening a new position worth an estimated $703M. The largest seller was Wellington Management Group, cutting an estimated $496M.

  • 346 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q4 2014, down from 348 in Q3 2014.
  • Funds reported $7.99B of SALIX PHARMACEUTICALS LTD DEL stock for Q4 2014, down 24% quarter-over-quarter.
  • 96 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q4 2014 and 94 closed out, a net change of +2 holders.
  • The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q4 2014 was Paulson & Co, an estimated $703M added.
  • The largest SALIX PHARMACEUTICALS LTD DEL seller in Q4 2014 was Wellington Management Group, an estimated $496M sold.

Based on aggregated 13F filings for Q4 2014.